Nursing and Health Professions
Cystic Fibrosis
100%
Recurrent Disease
100%
Combination Therapy
100%
Infection
100%
Confidence Interval
85%
Time
71%
Tobramycin
71%
Pseudomonas Infection
57%
Child
42%
Culture
42%
Standard
28%
Forced Expiratory Volume
28%
Weight
14%
Data Base
14%
Adult
14%
Adverse Event
14%
Quality of Life
14%
Drug Therapy
14%
Isolation
14%
Cost Effectiveness Analysis
14%
Placebo
14%
Analysis
14%
Mortality
14%
Follow up
14%
Height
14%
Publication
14%
Morbidity
14%
Sample
14%
Contrast
14%
Antibiotic Agent
14%
Female
14%
Hazard Ratio
14%
Secondary Prevention
14%
Eradication Therapy
14%
Medicine and Dentistry
Cystic Fibrosis
100%
Infection
100%
Therapeutic Procedure
100%
Recurrent Disease
100%
Pseudomonas aeruginosa
100%
Combination Therapy
70%
Tobramycin
50%
Inhalation
40%
Pseudomonas Infection
40%
Forced Expiratory Volume
20%
Analysis
10%
Hazard Ratio
10%
Mortality
10%
Quality of Life
10%
Age
10%
Cost-Effectiveness Analysis
10%
Anti-biotics
10%
Follow up
10%
Sputum
10%
Adverse Event
10%
Morbidity
10%
Drug Therapy
10%
Secondary Prevention
10%
Bacterium
10%
Randomized Controlled Trial
10%
Placebo
10%
Conflict
10%
Eradication Therapy
10%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Cystic Fibrosis
100%
Pseudomonas aeruginosa
100%
Recurrent Disease
100%
Tobramycin
50%
Inhalation
40%
Pseudomonas Infection
40%
Antibiotic Agent
10%
Mortality
10%
Morbidity
10%
Adverse Event
10%
Bacterium
10%